Rupal Sanjay Dhariwal

Ms. Rupal Sanjay Dhariwal

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2023 in Proteomes
Verified
Journal Article
Open access
PDF file
MJMukul Jain
Mukul Jain
RDRupal Sanjay Dhariwal
Rupal Sanjay Dhariwal
NPNIL SANJAY PATIL
NIL SANJAY PATIL
SOSandhya Ojha
Sandhya Ojha
RTReshma Tendulkar
Reshma Tendulkar
Prashant KaushikPrashant Kaushik
Prashant Kaushik
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder characterized by progressive cognitive decline and memory loss. Early and accurate diagnosis of AD is crucial for implementing timely interventions and developing effective therapeutic strategies. Proteome-based biomarkers have emerged as promising tools for AD diagnosis and prognosis due to their ability to reflect disease-specific molecular alterations. There is of great significance for biomarkers in AD diagnosis and management. It emphasizes the limitations of existing diagnostic approaches and the need for reliable and accessible biomarkers. Proteomics, a field that comprehensively analyzes the entire protein complement of cells, tissues, or bio fluids, is presented as a powerful tool for identifying AD biomarkers. There is a diverse range of proteomic approaches employed in AD research, including mass spectrometry, two-dimensional gel electrophoresis, and protein microarrays. The challenges associated with identifying reliable biomarkers, such as sample heterogeneity and the dynamic nature of the disease. There are well-known proteins implicated in AD pathogenesis, such as amyloid-beta peptides, tau protein, Apo lipoprotein E, and clusterin, as well as inflammatory markers and complement proteins. Validation and clinical utility of proteome-based biomarkers are addressing the challenges involved in validation studies and the diagnostic accuracy of these biomarkers. There is great potential in monitoring disease progression and response to treatment, thereby aiding in personalized medicine approaches for AD patients. There is a great role for bioinformatics and data analysis in proteomics for AD biomarker research and the importance of data preprocessing, statistical analysis, pathway analysis, and integration of multi-omics data for a comprehensive understanding of AD pathophysiology. In conclusion, proteome-based biomarkers hold great promise in the field of AD research. They provide valuable insights into disease mechanisms, aid in early diagnosis, and facilitate personalized treatment strategies. However, further research and validation studies are necessary to harness the full potential of proteome-based biomarkers in clinical practice.

21 January 2024 in Biocatalysis and Agricultural Biotechnology
Verified
Journal Article
Closed access
MJMukul Jain
Mukul Jain
RDRupal Sanjay Dhariwal
Rupal Sanjay Dhariwal
KBKrupanshi Bhardava
Krupanshi Bhardava
SDSarvjeet Das
Sarvjeet Das
MSMushtaque Shaikh
Mushtaque Shaikh
Prashant KaushikPrashant Kaushik
Prashant Kaushik

24 September 2024 in South African Journal of Botany
Verified
Journal Article
Open access
Kirtan DaveKirtan Dave
Kirtan Dave
PKPrashant Kaushik
Prashant Kaushik
NPNIL SANJAY PATIL
NIL SANJAY PATIL
RDRupal Sanjay Dhariwal
Rupal Sanjay Dhariwal
MSMeenakshi Sharma
Meenakshi Sharma
MJMukul Jain
Mukul Jain